EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Metabolic profiling of human melanoma cell lines with high and low metastatic capacity by 1H-NMR spectroscopy

Nima Rezvani Kakhki, Zita Hegedűs, József Tóvári, Arash Mirzahosseini iD, Béla Noszál, Márta Kraszni iD

PLOS One · 01.07.2026 · 21 (7) · e0352639

DOI: 10.1371/journal.pone.0352639 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS One, online erschienen am 01.07.2026. Verfasst von Nima Rezvani Kakhki und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Chemistry, Semmelweis University, Budapest, Hungary. Hauptthemen laut MEDLINE: Melanoma, Metabolome, Metabolomics, Proton Magnetic Resonance Spectroscopy. Die Arbeit nennt 80 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Nemzeti Kutatási Fejlesztési és Innovációs Hivatal, National Research, Development and Innovation Office.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Melanoma is one of the most aggressive forms of skin cancer due to its high metastatic potential and mortality rate. Although understanding of metabolic reprogramming in melanoma has advanced, the connection between metabolic alterations and metastatic capacity remains incomplete.

Aim

This study aimed to characterize the metabolic profiles of human melanoma cell lines with high (HT168-M1) and low (WM983B) metastatic potential, and to compare them with each other and also with the metabolic profile of normal human fibroblasts (MRC-5), in order to identify key metabolites and metabolic pathways associated with metastatic behavior.

Methods

Non-targeted metabolomic profiling using ¹H-NMR spectroscopy was applied to hydrophilic extracts of the three cell lines. Multivariate statistical analyses (PCA and PLS-DA) were used to identify discriminating metabolites, and pathway analysis was performed to determine altered metabolic networks.

Results

Several metabolic pathways were significantly altered in melanoma cells compared to fibroblasts, including starch and sucrose metabolism, alanine, aspartate and glutamate metabolism, and glutathione metabolism. Metabolites showing more than two-fold differences included elevated UDP-glucose, ATP, glycerophosphocholine, GTP, creatine and glutathione in the melanoma cells, and reduced glucose, glutamine and 1-methylnicotinamide in fibroblasts. Comparison of the metabolites of melanoma cell lines with differing metastatic potential revealed changes in taurine and hypotaurine, β-alanine-, glutathione-, and amino acid metabolism. Metabolites showing the largest concentration changes were UDP-glucose, glutathione, NAD + , alanine and β-alanine.

Conclusion

Metabolomic profiling revealed distinct metabolic reprogramming between melanoma and normal fibroblasts, characterized by enhanced glycolysis and glutathione-dependent antioxidant defense. Highly metastatic melanoma cells demonstrated stronger redox adaptation and altered amino acid utilization, with elevated glutathione and glutamate and reduced NAD⁺ and pyruvate, indicating a metabolic shift toward oxidative stress resistance.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MelanomaMetabolomeMetabolomicsProton Magnetic Resonance SpectroscopyHumansCell Line, TumorNeoplasm MetastasisFibroblastsMetabolic ReprogrammingMetabolic Networks and PathwaysMagnetic Resonance SpectroscopyPrincipal Component Analysis

Autor:innen und Institutionen

  • Department of Pharmaceutical Chemistry, Semmelweis University, Budapest, Hungary.
  • Center for Pharmacology and Drug Research & Development, Semmelweis University, Budapest, Hungary.
  • National Korányi Institute of Pulmonology, Budapest, Hungary.
  • Department of Experimental Pharmacology and the National Tumor Biology Laboratory, National Institute of Oncology, Budapest, Hungary.

ORCID-Profile: Arash Mirzahosseini, Márta Kraszni

Förderung

  • Nemzeti Kutatási Fejlesztési és Innovációs Hivatal
  • National Research, Development and Innovation Office

Zitieren

APA

Kakhki, N. R., Hegedűs, Z., Tóvári, J., Mirzahosseini, A., Noszál, B., & Kraszni, M. (2026). Metabolic profiling of human melanoma cell lines with high and low metastatic capacity by 1H-NMR spectroscopy. PLOS One, 21(7), e0352639. https://doi.org/10.1371/journal.pone.0352639

Vancouver

Kakhki NR, Hegedűs Z, Tóvári J, Mirzahosseini A, Noszál B, Kraszni M. Metabolic profiling of human melanoma cell lines with high and low metastatic capacity by 1H-NMR spectroscopy. PLOS One. 2026;21(7):e0352639. doi:10.1371/journal.pone.0352639

BibTeX
@article{Kakhki2026,
  author = {Kakhki, Nima Rezvani and Hegedűs, Zita and Tóvári, József and Mirzahosseini, Arash and Noszál, Béla and Kraszni, Márta},
  title = {Metabolic profiling of human melanoma cell lines with high and low metastatic capacity by 1H-NMR spectroscopy},
  journal = {PLOS One},
  year = {2026},
  volume = {21},
  number = {7},
  pages = {e0352639},
  doi = {10.1371/journal.pone.0352639}
}
Kostenlos starten →